Cano Health CEO Marlow Hernandez resigns; Mark Kent appointed Interim CEO

Cano Health, Inc.

CEO Marlow Hernandez resigned effective June 16, 2023; remains on Board.
Mark Kent, current Chief Strategy Officer, appointed Interim CEO effective immediately.
Kent receives $475k base salary, $325k target cash incentive, $1.5M annual equity, $1.5M RSUs vesting June 2024.
Board will conduct external search for permanent CEO and refresh Board with new independent directors.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Mark Kent

Interim Chief Executive Officer

Cano Health, Inc.

Effective: 2023-06-16
Filed: June 20, 2023, 7:59 PM ET

Effective immediately, on June 16, 2023, the Board of Directors (the “ Board ”) of Cano Health, Inc. (the “ Company ”) elected the Company’s current Chief Strategy Officer, Mr. deMarquette (“ Mark ”) Kent, as the Company’s Interim Chief Executive Officer (the “ Interim CEO ”).

Departed

Marlow Hernandez

Chief Executive Officer

Cano Health, Inc.

Effective: 2023-06-16
Successor: Mark Kent
Filed: June 20, 2023, 7:59 PM ET

Mr. Kent will replace Dr. Marlow Hernandez, who tendered his resignation as the Company’s Chief Executive Officer, as well as all positions he holds at the Company’s subsidiaries, effective immediately on June 16, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Kent was appointed as Interim Chief Executive Officer at Cano Health, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

Effective immediately, on June 16, 2023, the Board of Directors (the “ Board ”) of Cano Health, Inc. (the “ Company ”) elected the Company’s current Chief Strategy Officer, Mr. deMarquette (“ Mark ”) Kent, as the Company’s Interim Chief Executive Officer (the “ Interim CEO ”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Marlow Hernandez resigned as Chief Executive Officer at Cano Health, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

Mr. Kent will replace Dr. Marlow Hernandez, who tendered his resignation as the Company’s Chief Executive Officer, as well as all positions he holds at the Company’s subsidiaries, effective immediately on June 16, 2023.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-23-169651

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.